Sensex
77,264.51 profit arw 330.92 (0.43%)
Nifty
24,175.65 profit arw 84.80 (0.35%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 25-Aug-2026
Hot Pursuit
25-Aug-2026     22:01

AstraZeneca Pharma India Limited receives a stay on NPPA’s demand notice regarding overcharging for Betaloc-50 tablets

AstraZeneca Pharma India Limited announced that the Hon'ble High Court of Delhi has stayed the operation of a demand notice dated July 27, 2026, issued by the National Pharmaceutical Pricing Authority (NPPA) alleging overcharging for Betaloc-50 tablets, until a hearing on February 10, 2027. The NPPA alleges that AstraZeneca Pharma India Ltd. sold the medication at a price exceeding the ceiling set under the Drugs (Prices Control) Order, 2013, between June and July 2016, resulting in a demand for recovery of overcharged amounts plus interest; as part of the stay, the company is required to deposit 15% of the amount mentioned in the Demand Notice with the Registrar General of the Delhi High Court.

INDIAN INDICES

Sensex

77,264.51 330.92 (0.43%)

Nifty

24,175.65 84.80 (0.35%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,584.80 19.05(0.07%)